Headlands Research Acquires Trial Management Associates
With research sites in North and
"The acquisition of TMA further demonstrates our commitment to strategic growth," said
TMA is headquartered in
"The missions of TMA and Headlands Research are synchronous: to improve lives by advancing innovative medical therapies," said
To learn more about Headlands Research and its extensive network of research sites, visit https://headlandsresearch.com, contact [email protected], or follow the company on LinkedIn.
About Headlands Research
Headlands Research is a multinational integrated clinical trial site organization with a mission to improve lives by advancing innovative medical therapies. Its group of exceptional sites focuses on large-volume recruitment of diverse and specialty patient populations while delivering the highest quality data. Headlands Research's principal investigators are proven industry leaders in their fields with expertise in a wide variety of indications. Utilizing expert recruitment strategies and access to diverse patients through its site databases and physician partnerships, Headlands Research has successfully completed more than 5,000 clinical trials. Additional information about the company is available at www.headlandsresearch.com.
Contact:
Phone: 919-270-8054
Email: [email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/headlands-research-acquires-trial-management-associates-302295382.html
SOURCE Headlands Research
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Global Sae-A Group Affiliate Sae-A Trading Named UNGC LEAD Company for Second Consecutive Year
- Sasken Selected to Support Strategic Connectivity Platform Programme with Leading European Automotive Software Company
- From Scientific Discovery to Coexistence: Ya'an Offers a Comprehensive Model for Giant Panda Conservation
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share